Wall Street brokerages expect Valeritas Holdings Inc (NASDAQ:VLRX) to announce ($0.56) earnings per share for the current quarter, Zacks Investment Research reports. Two analysts have issued estimates for Valeritas’ earnings. Valeritas posted earnings of ($1.62) per share during the same quarter last year, which suggests a positive year-over-year growth rate of 65.4%. The company is scheduled to report its next quarterly earnings results on Wednesday, November 14th.
On average, analysts expect that Valeritas will report full year earnings of ($2.76) per share for the current year. For the next financial year, analysts expect that the business will report earnings of ($2.03) per share. Zacks Investment Research’s EPS averages are an average based on a survey of sell-side analysts that that provide coverage for Valeritas.
Valeritas (NASDAQ:VLRX) last announced its quarterly earnings data on Tuesday, August 7th. The company reported ($0.62) earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of ($0.73) by $0.11. The business had revenue of $6.50 million during the quarter, compared to analysts’ expectations of $6.30 million. Valeritas had a negative return on equity of 1,768.69% and a negative net margin of 205.12%.
Institutional investors and hedge funds have recently modified their holdings of the stock. Bainco International Investors bought a new stake in shares of Valeritas in the second quarter worth $228,000. C WorldWide Group Holding A S grew its holdings in shares of Valeritas by 28.0% in the second quarter. C WorldWide Group Holding A S now owns 316,194 shares of the company’s stock worth $424,000 after acquiring an additional 69,216 shares during the period. Finally, Essex Investment Management Co. LLC bought a new stake in shares of Valeritas in the second quarter worth $448,000. 7.38% of the stock is owned by institutional investors.
Shares of VLRX stock traded up $0.01 during mid-day trading on Thursday, hitting $1.33. The company’s stock had a trading volume of 5,359 shares, compared to its average volume of 247,491. Valeritas has a 52-week low of $0.78 and a 52-week high of $6.79. The company has a debt-to-equity ratio of 13.66, a current ratio of 4.03 and a quick ratio of 3.42. The stock has a market capitalization of $24.86 million, a P/E ratio of -0.15 and a beta of 4.14.
Valeritas Company Profile
Valeritas Holdings, Inc, a commercial-stage medical technology company, focuses on the development and commercialization of technologies to treat patients with Type 2 diabetes in the United States and China. It offers V-Go, a wearable insulin delivery device for basal-bolus therapy. The company also develops h-Patch, a controlled delivery technology platform; Mini-Ject technology for needle-free injection systems; and Micro-Trans technology for microneedle design, fabrication, and drug delivery.
Featured Article: Why is the ex-dividend date different from the record date?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Valeritas Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Valeritas and related companies with MarketBeat.com's FREE daily email newsletter.